Household demand for typhoid fever vaccines in Hue, Vietnam

Health Policy and Planning

Volumn 21, Issue 3, 2006, Pages 241-255

  Canh, Do Gia ^a,g   Whittington, Dale ^b,h   Thoa, Le Thi Kim ^c,i   Utomo, Nugroho ^b   Hoa, Nguyen Thai ^d,j   Poulos, Christine ^e,l   Thuy, Dang Thi Dieu ^d,j   Kim, Dohyeong ^b   Nyamete, Andrew ^f,k   Acosta, Camilo ^f  

^a NATIONAL INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Viet Nam)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Medical College   (Viet Nam)

^d Preventive Medicine Center   (Viet Nam)

^e RTI INTERNATIONAL   (United States)

^f International Vaccine Institute   (South Korea)

^g National Institute of Hygiene and Epidemiology   (Viet Nam)

^h UNIVERSITY OF NORTH CAROLINA   (United States)

ⁱ HANOI MEDICAL UNIVERSITY   (Viet Nam)

^j Provincial Preventive Medicine Center of Thua Thien Hue Province   (Viet Nam)

^k International Vaccine Institute's Diseases of the Most Impoverished Program

^l Social   (United States)

more..

Author keywords

Contingent valuation; Private demand; Typhoid fever vaccines; Vaccines; Willingness to pay

Indexed keywords

TYPHOID VACCINE;

DRUG COST; HEALTH BEHAVIOR; HEALTH CARE POLICY; HOUSEHOLD; HUMAN; INCOME; MULTIDRUG RESISTANCE; QUESTIONNAIRE; REVIEW; SALMONELLA TYPHI; TYPHOID FEVER; VACCINATION; VIET NAM;

ADULT; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES; VIETNAM;

EID: 33646785356     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czl009     Document Type: Review

References (21)

1. Bahl R, Sinha A, Poulos C et al. 2004. Costs-of-illness of typhoid fever in an Indian urban slum community: implications for vaccination policy. Journal of Health, Nutrition, and Population 22: 304-10.
2. Cameron TA, James MD. 1987. Efficient estimation methods for "closed-ended" contingent valuation surveys. Review of Economics and Statistics 69: 269-76.
3. Cropper ML, Haile M, Lampietti J, Poulos C, Whittington D. 2004. The demand for a malaria vaccine: evidence from Ethiopia. Journal of Development Economics 75: 303-18.
4. DeRoeck D, Jodar L. 2004. Update on policy issues regarding typhoid and cholera immunization in Vietnam: report of country visit (April 5-12, 2004). Diseases of the Most Impoverished Project Report. Seoul, Korea: International Vaccines Institute.
5. DeRoeck D, Nyamete A, Mahoney R, Clemens J. 2002. Policymakers' views regarding typhoid fever and new generation typhoid vaccines in Asia. Unpublished document.
6. Haab T, McConnell K. 2002. Valuing environmental and natural resources: the econometrics of non-market valuation. Cheltenham, UK: Edward Elgar.
7. Hanemann WM. 1984. Welfare evaluations in contingent valuation experiments with discrete responses. American Journal of Agricultural Economics 66: 5-13.
8. Hessel L, Debois H, Fletcher M, Dumas R. 1999. Experience with Salmonella typhi Vi capsular polysaccharide vaccine. European Journal of Clinical Microbiology and Infectious Diseases 18: 609-20.
9. Hoa NT, Diep TS, Wain J et al. 1998. Community-acquired septicaemia in southern Viet Nam: the importance of multidrug-resistant Salmonella typhi. Transactions of the Royal Society of Tropical Medicine and Hygiene 92: 503-8.
10. Lin FC, Vo AH, Phan VB et al. 2000. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. American Journal of Tropical Medicine and Hygiene 62: 644-8.
11. McFadden D. 1974. Conditional logit analysis of discrete choice behavior. In: Zarembka P (ed). Frontiers of econometrics. New York: Academic Press.
12. Mitchell R, Carson R. 1989. Using surveys to value public goods: the contingent valuation method. Washington, DC: Resources for the Future.
13. National Institute of Hygiene and Epidemiology (NIHE). 2002. Thua Thien Province statistics yearbook: regular report. Hanoi: Statistics Department of Communicable Disease.
14. Pang T, Levine M, Ivanoff B, Wain J, Finlay BB. 1998. Typhoid fever - important issues still remain. Trends in Microbiology 6:131-3.
15. Sinha, A, Sazawal S, Kumar R et al. 1999. Typhoid fever in children aged less than 5 years. The Lancet 354: 734-37.
16. Suraratdecha C, Ainsworth M, Tangcharoensathien V, Whittington D. 2005. The private demand for an HIV/AIDS vaccine in Thailand. Health Policy 71: 271-87.
17. Whittington D. 1998. Administering contingent valuation surveys in developing countries. World Development 26: 21-30.
18. Whittington D. 2002. Improving the performance of contingent valuation studies in developing countries. Environmental and Resource Economics 22: 323-67.
19. World Health Organization (WHO). 1998. Report of the Scientific Group of Experts (SAGE): Children's Vaccine Initiative and Global Programme on Vaccines. Geneva: WHO. Document WHO/GPV/98.06.
20. Yang HH, Wu CG, Xie GZ et al. 2001a. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in southwestern China. Bulletin of the World Health Organization 79: 625-31.
21. Yang HH, Kilgore PE, Yang LH et al. 2001b. An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine. Journal of Infectious Diseases 183: 1775-80.